Visit Booth #820, October 19–22 at the Georgia World Congress Center
Carlsbad, CA— DCN Dx, a specialist in lateral flow diagnostics development, manufacturing, and IVD regulatory consulting and clinical research, will exhibit at IDWeek 2025, taking place October 19–22 at the Georgia World Congress Center in Atlanta.
The company will be located at Booth #820, where attendees can see the miniDxR™ platform on display and meet with DCN Dx experts to explore how the company’s IVD CRO services and point-of-care CDMO expertise can accelerate diagnostic development.
DCN Dx offers integrated services that span the full IVD product lifecycle—from early-stage assay design to full-service clinical research and regulatory affairs. Its regulatory affairs services provide complete support for U.S. and international approvals, including regulatory strategy development, submission preparation, direct interaction with agencies, trial oversight, and post-market compliance. This CRO offering ensures diagnostic developers have a seamless and coordinated path to market.
Known for its deep expertise in point-of-care diagnostics and its role as a single-source CDMO-CRO partner, DCN Dx helps clients accelerate development timelines while navigating complex regulatory landscapes with confidence.
“Our mission is to support diagnostic developers with customized solutions that meet technical, clinical, and regulatory needs,” said Mitzi Rettinger, DCN Dx’s Chief Revenue Officer. “We look forward to connecting with innovators at IDWeek to demonstrate how our team can help bring diagnostics to market faster and with meaningful impact for patients.”
IDWeek 2025 is the joint annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP). It is recognized as the premier forum for ID health professionals of varied backgrounds to collaborate, connect, and learn from one another’s expertise to advance science and improve patient care and public health. The 2025 meeting will take place October 19–22 in Atlanta, Georgia, with both in-person and virtual participation options.
Attendees are encouraged to schedule a meeting with the DCN Dx team in advance to ensure dedicated time with subject matter experts.
To request a meeting with DCN Dx at IDWeek 2025, visit https://shorturl.at/bzJVJ.
About DCN Dx
DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx’s multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research and regulatory services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory affairs services.
DCN Dx’s personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx’s clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
